Iron Deficiency and Iron Deficiency Anemia: What You Need to Know
Iron deficiency and the anemia that can result from it are serious conditions Learn more from Regional Cancer Care Associates
HIPAA Alert: Potential Data Breach Learn More
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
Thousands of patients each year have come to rely on the expertise, dedication and compassion of Regional Cancer Care Associates with locations in New Jersey, Connecticut, Maryland, Massachusetts and the Washington, D.C., area.
RCCA’s commitment to providing excellent care shows in every aspect of the work these physicians do. It is why RCCA has been successful, and why its physicians are routinely selected as the top in their field.
This year, 11 doctors from RCCA were honored as 2025 Top Doctors in Women’s Health as selected by health care research and information company Castle Connolly. The selection process is not only independent, but exhaustive, and includes peer nomination, research, review and screening by America’s most trusted source for finding top doctors.
Using cutting-edge therapies, sophisticated diagnostics, and a warm, personal approach, physicians at Regional Cancer Care Associates’ 19 New Jersey locations treat their patients in a supportive and hopeful environment.
Most importantly, RCCA delivers this care close to a patient’s home, easing the burden for those who would rather not travel to New York or Philadelphia. Loved ones can instead focus on providing support and strength, while patients can focus on healing. Additionally, a Journal of Clinical Oncology showed that receiving cancer care close to home reduces hospitalizations.
The physicians named to Castle Connolly’s prestigious list of 2025 Top Doctors in Women’s Health in New Jersey are:
Of the 850,000 practicing physicians in the U.S., just 7% are named to the Top Doctors list. The recognition is given following a comprehensive review process conducted by an experienced medical review board. Reviewers consider a doctor’s skills, professionalism, training/qualifications, experience, competence, outcomes and achievements as well as his or her relational skills and empathy toward patients.
RCCA has more than 100+ cancer specialists who treat patients in 26 RCCA care centers in New Jersey, Connecticut, Maryland, Massachusetts and the Washington, D.C., area. Those oncologists see more than 26,000 new patients each year and provide care to more than 245,000 established patients, collaborating closely with their patients’ other physicians.
RCCA is the top choice of many patients due to the comprehensive services offered by its physicians, including immunotherapies and targeted therapy. Patients also have access to a range of clinical trials. In addition to serving patients who have solid tumors, blood-based cancers, and benign blood disorders such as anemia, RCCA care centers also provide infusion therapy services to people with a number of non-oncologic conditions — including multiple sclerosis, Crohn’s disease, asthma, and rheumatoid arthritis — who take intravenously administered medications.
To learn more about RCCA, call 844-928-0089 or contact us.
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Iron deficiency and the anemia that can result from it are serious conditions Learn more from Regional Cancer Care Associates
The outlook for treating and preventing cervical cancer is brighter thanks to new treatment options. Learn more from Regional Cancer Care Associates.
The International Conference on Hematology and Oncology awarded a Medal of Honor to Dr. James Orsini of Regional Cancer Care Associates
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.